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Abstract:  
The value of salivary biomarkers for diagnostic and prognostic assessments has become increasingly well established in medicine, 
pharmacology, and dentistry.  Certain salivary components mirror the neuro-endocrine status of the organism.  Other saliva products 
are protein in nature, and can serve to reflect immune surveillance processes. The autonomic nervous system regulates the process of 
salivation, and the concentration of yet other salivary components, such as α-amylase, which provide a reliable outcome measure of 
the sympathetic response.  Here, we discuss molecular technologies that have permitted giant steps in the utilization of salivary 
samples and micro-fluidics for the benefit of diagnostic medicine and dentistry, and their putative role in springing forward research in 
psychobiology. 
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Background: 
That invertebrates exhibit structures that produce a saliva-like 
substance demonstrates the critical importance of this 
physiological fluid throughout evolution.  In higher vertebrates, 
including humans, parotideal, sublingual and submandibular 
salivary glands produce saliva, besides smaller glands spread 
over the oral cavity, including the tip of the tongue. 
Histologically, salivary glands consist of blind ducts surrounded 
by capillary vessels and embedded in connective tissue. Saliva 
obtains by filtering capillary blood through acinar cell 
membranes, thus preventing certain blood components from 
passing, including hormone-binding proteins, and making of 
saliva a fluid distinct from blood plasma or serum. Saliva is 
distinct from sputum, the mucus or phlegm expectorated from 
the respiratory tract and mixed with saliva.   
 
Saliva is primarily water buffered (pH: 6.4–7.4) by its 
biochemical constituents:  electrolytes, minerals, hormones (e.g., 
cortisol; diurnal peak: 13.8–48.9 nmol/l, compared to blood: 
190–690 nmol/l), enzymes, immunoglobulins, cytokines (Figure 
1), and other analytes. The physiological roles of saliva include 
moistening food to aid chewing and swallowing, initiating 
digestion through salivary enzymes (e.g., Sα-amylase, 
EC3.2.1.1; 11,900–305,000 U/I, compared to blood: < 220 U/l), 
and cleansing the mouth and teeth by washing away bacteria and 
food particles. 
 
The value of saliva as biological fluid for the detection of 
diagnostic and prognostic biomarkers has become increasingly 
well established. Sample collection is non-invasive, painless, 
and possible several times a day to provide accurate and reliable 
assessments of diurnal fluctuations of, for example, the 
unbound, biologically active, form of certain hormones and 
drugs. The autonomic nervous system regulates the process of 
salivation, and the concentration of certain salivary components 
(e.g., Sα-amylase) mirrors the sympathetic response.  Other 
salivary constituents (e.g., cortisol; cytokines) reflect 
physiologic endocrine-immune regulation. Together, salivary 
cortisol and α-amylase can outline the neuro-endocrine status.  
Yet other peptides in saliva manifest blood circulating level, and 
have diagnostic utility.  For example, we have shown that 
salivary  α-Amyloid protein, the main constituent of neuronal 
plaques, is on average 3.34 fold higher in patients with probable 
Alzheimer’s disease (AD) compared to aged- and sex-matched 
normal subjects, although no significant correlation between 
plasma and salivary levels (r=0.489) was obtained.  We also 
compared several pro-inflammatory cytokines (IL-1α, IL-6, 
TNFα), TH1 cytokines (IL-2, α-IFN, IL-12) and TH2 cytokines 
(IL-4), as well as markers of apoptosis (FasL, Annexin V) in 
saliva and plasma samples from normal individuals. That our 
salivary samples were not contaminated with serum exudate due 
to oral ulcerations and the like was confirmed by the lack of 
correlation for any of the pro-inflammatory cytokines we tested.  
A significant correlation was detected between plasma and 
salivary concentrations of Annexin V (r=0.611, p<0.05), but not 
in FasL levels (r=-.217).  Newer HIV/AIDS tests reliably detect 
salivary antibodies to HIV-1.   
 
Analyzing nanoliter samples of saliva through molecular 
biology (i.e., microfluidics) have spawned powerful techniques 
for making salivary diagnostics possible. Quantitative PCR 
(qPCR) provides critical data to forensic investigations, and to 
molecular medicine since saliva contains putative genetic 
markers for a variety of genetic disorders, including AD, cystic 
fibrosis, breast cancer, childhood respiratory disease, gum and 
periodontal disease, or oral cancer. 
 
Description: 
Molecular technologies have permitted giant steps in the 
utilization of salivary samples and microfluidics for improved 
diagnosis. For example, high-density oligonucleotide 
microarrays and qPCR analysis yielded thousands of salivary 
mRNAs, which provided potential biomarkers to identify 
populations of patients at high risk for oral and systemic 
diseases. The mRNA profiles in putatively normal saliva 
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a novel clinical approach to salivary diagnostics, now termed 
Salivary Transcriptome Diagnostics (STD). [2] 
 
The diagnostic value of STD was tested in patients with oral 
squamous cell carcinoma. RNA isolated from unstimulated 
saliva was amplified by two-round linear amplification (T7 
RNA polymerase), and profiled for the human salivary 
transcriptome (Human Genome U133A microarrays). Statistical 
analysis differentiated the patterns of gene expression, and was 
validated by qPCR and by receiver-operating curve analysis. 
Close to 1,700 genes were obtained that showed a significant 
difference in saliva expression between cancer patients and 
control subjects. Seven cancer-related mRNA biomarkers were 
identified: IL8, IL1α, DUSP1, HA3, OAZ1, S100P, and SAT, 
which together yielded a robust diagnostic sensitivity and 
specificity greater than 90%. Taken together, the data show that 
salivary transcriptome profiling can be exploited as a 
reproducible tool for early cancer detection, putatively for other 
pathological conditions, and for normal health surveillance. [3]   
 
The protein counterparts of salivary mRNAs often, but not in 
every instance (60-75%) co-exist in saliva. Therefore, new 
developments in the molecular characterization of salivary 
components use global profiling of human saliva proteomes and 
transcriptomes by mass spectrometry (MS) to supplement STD. 
Expectations are that the saliva transcriptome will increasingly 
provides insights into the boundary of the saliva proteome. [4] 
 
The full characterization of the salivary proteome, and its 
underlying transcriptome, will eventually serve prognostic 
clinical sciences as well.  We have discussed elsewhere the 
process of allostasis, the physiological events that mirror the 
organism’s adaptation and recovery from physical, physiological 
or psycho-cognitive stress.  Considering the fact that the salivary 
components describe and characterize the physiological status, it 
is self-evident that the next generation of psychobiological 
research will entail the characterization of the salivary proteome 
and of its underlying transcriptome. 
 
Case in point, the assessment of Sα-amylase is a more sensitive 
and more specific measurement than blood pressure or heart rate 
in healthy adult subjects. The stress response has two principal 
facets: the neuro-endocrine, which involves corticotropin-release 
hormone, activation of the hypothalamic-pituitary-adrenal axis 
and the secretion of cortisol into circulation.  Cortisol is then 
filtered through the acinar cell membrane of the salivary glands, 
and is found in saliva in the free unbound form. Secondly, the 
stress response involves activation of the autonomic nervous 
system, release of catecholamines (e.g., plasma norepinephrine, 
pNE), and sympatho-mimetic manifestations, such as increase 
salivation, and increase secretion of Sα-amylase. Sα-amylase 
levels increase under a variety of physical (i.e., exercise, heat 
and cold) and psychological (i.e., written examinations) 
challenges, and are predictive of pNE levels. Salivary or plasma 
cortisol levels do not always correlate with Sα-amylase 
following stress, confirming that the two pathways are distinct 
and complementary. [5, 6] 
 
The Trier psycho-socio/cognitive situational stress (mental 
arithmetic task and free speech in front of an audience) is a 
useful paradigm, which permits comparative study of the 
psychobiology of stress.  In a group of normal adult subjects, the 
Trier stress led to significant differences between the response 
and the resting states in Sα-amylase and cortisol levels, and in 
heart rate. [5] However, the Sα-amylase responses expressed as 
the area under the curve did not correlate with the general 
responses in pNE and cortisol. [6]    
 
In an earlier study, saliva and blood samples were 
simultaneously collected from normal healthy men for 
assessment of pNE and Sα-amylase at regular intervals 
following a variety of stress paradigms.  The regressions of Sα-
amylase on pNE concentrations were significant for both 
physical and psycho-cognitive situational stressful challenges: 
physical exercise stress led to a 3-fold average rise in Sα-
amylase, and a 5-fold average rise in pNE. The levels of Sα-
amylase and pNE returned to normal by 30-45 min post-stress.  
The psycho-cognitive stress (written examination) also led to a 
parallel rise in Sα-amylase and pNE.  Changes in plasma cortisol 
levels were not correlated with pNE or Sα-amylase. [7] 
 
Changes in salivation often accompany the stress response, 
therefore it is important to establish whether changes in Sα-
amylase levels truly mirror the physiological response to stress, 
or merely confound altered salivary flow. Increases in Sα-
amylase proteome profile can be inhibited by the adrenergic 
blocker propranol, but α-adrenergic agonists stimulate levels Sα-
amylase release without increasing salivary flow.  This 
important observation suggests that the same stimuli that 
increase sympathetic arousal activate sympathetic input to the 
salivary glands, independently from salivary gland flow.   
Normal human subjects who underwent the Trier test were 
tested for both salivary flow and Sα-amylase levels. The data 
establish that stress-induced increases in Sα-amylase levels were 
correlated with increases of the proteomic profile of interest but 
not with flow rate. [8] 
 
In a natural interpersonal stress environment (parents/guardians 
and adolescents reporting on adolescents' aggressive behavior) 
cortisol and Sα-amylase levels accounted for 7% of the variance 
in parent-reported adolescent aggression. At lower Sα-amylase 
levels, lower cortisol responses corresponded to higher 
aggression ratings, but at high Sα-amylase concentrations, the 
cortisol response was not related to aggression. These results 
underscore the reliability of salivary outcome measures, and the 
importance of multiple biomarkers in psycho-social research, 
such as psychobiological paradigms models of adolescent 
aggression. [9] 
 
Optimism and positive emotional states also modify the salivary 
biomarker profile. Optimism vs. pessimism (revised Life 
Orientation Test), and positive vs. negative affectivity (Chinese 
Affect Scale) were compared in an experimental setting, and the 
diurnal rhythm of salivary cortisol monitored in a group of 80 
Hong Kong Chinese over 24 h on two consecutive days. The 
data showed striking statistical relationships in that participants 
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secretion, when the effect of pessimism and mood were 
controlled. The outcome was greater among men, compared to 
women whose levels of AM cortisol were generally higher than 
men. The Optimism effect was not observed during the 
descending period of the cortisol diurnal flux (i.e., PM). 
Generalized positive affect was correlated with lower salivary 
cortisol levels in PM, when the effects of negative affect and 
mood states were controlled, but not during the ascending limb 
of the cortisol diurnal curve (i.e., AM). [10] In a separate study, 
positive mood with respect to personal relevance of daily 
activities in relation to self-set work and family goals were 
shown to be correlated with decreased secretion of salivary 
cortisol. The relationship between the goal relevance of daily 
activities and cortisol was shown statistically to be partially 
mediated by affect quality. [11]  Taken together, these data 
suggest that positive psychological stimuli alter salivary 
biomarkers as well as stressful stimuli, and that salivary levels 
of cortisol may provide correlates of psychological well-being. 
The extent to which these observations relate to the salivary 
proteomic profile (e.g., α-amylase) remains to be established. 
 
 
Figure 1: Circadian fluxes of critical cytokines in human saliva. Whole saliva samples were obtained from a healthy 35-years old 
male at 2 h intervals. Samples were assayed by enzyme-linked immunosorbent assay (ELISA). Overnight data samples were 
extrapolated statistically. Circadian flux cosinor analyses were performed as previously described elsewhere. Some of the data 
presented in this figure (i.e., IL-6) were published elsewhere [1] and are presented here for comparison purposes only. Panel A: IL-8, 
a cytokine responsible for immune cell migration; Panel B: IL-1β, a proinflammatory cytokine; Panel C: IL-6, a proinflammatory 
cytokine; Panel D: IL-2, a TH1 cytokine, T cell activation, proliferation & maturation; Panel E: γ-IFN, a TH1 cytokine, T cell 
activation, proliferation & maturation; Panel F: IL-10, a regulatory cytokine that blunts γ-IFN and favors B cell maturation; Panel G: 
IL-12: a regulatory cytokine that blunts IL-10 and favors γ-IFN Panel H: IL-4, a TH2 cytokine, B cell maturation Bioinformation by Biomedical Informatics Publishing Group                   open access 
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